Homepage > Company > Media > Pharma News > 2017 > Paratek Pharmaceuticals soars after revealing it is to appear at five investor conferences

Paratek Pharmaceuticals soars after revealing it is to appear at five investor conferences

Two biotechs - Paratek and Intra-Cellular - were the stocks to have on Wednesday morning.

RISERS

Paratek Pharmaceuticals Inc (NASDAQ:PRTK), up 32% at US$25.075

The tetracycline chemistry specialist surged as it revealed it would participate in five upcoming investor conferences.

Intra-Cellular Therapies Inc (NASDAQ:ITCI), up 32% at US$14.82.

The shares were wanted after the biotech announced a positive regulatory update on its schizophrenia program.

The US Food and Drug Administration (FDA) had been concerned that its candidate, lumateperone, had shown worrying signs of toxicity when used in tests on animals, but has been convinced that humans are different to other animals.

FALLERS

Precipio Inc (NASDAQ:PRPO), down 47% at US$2.35.

The biotech's shares slumped as it announced plans to raise US$6mln through an underwritten stock offering. The units being offered include convertible preferred stock that can be converted into Precipio common stock at US$2.50 a pop.

23 Aug 2017

http://www.proactiveinvestors.co.uk/

Read also

FDA warns vs fake versions of popular medicines

MANILA, Philippines - counterfeit versions of some popular over-the-counter pain relievers and flu medicines are circulating in the market, the Food and Drug Administration (FDA) reported. ...

Japan's Eisai inks $2 B oncology deal with China-based startup Bliss Biopharma

Cognixion, a developer of non-invasive Brain-Computer Interface (BCI) and Augmented Reality (AR) technology, has announced that the US Food and Drug Administration (FDA) has granted its device Brea...

Cognixion receives FDA Breakthrough Device Designation for assisted communication device

EMA to review CTIS transparency rules

Public consultation seeks the best methods for balancing transparency with confidentiality in the EU Clinical Trials Information System, says the European Medicines Agency. ...